Profiel
Nabil A.
Abadir is currently the Global Chief Medical Officer & Senior VP at Amarin Corp.
Plc.
Prior to this role, he served as the Executive VP-Medical & Scientific Affairs at Clementia Pharmaceuticals, Inc.
Actieve functies van Nabil A. Abadir
| Bedrijven | Functie | Begin |
|---|---|---|
| AMARIN CORPORATION PLC | Hoofd Techniek/Wetenschap/O&O | 01-04-2022 |
Eerdere bekende functies van Nabil A. Abadir
| Bedrijven | Functie | Einde |
|---|---|---|
| CLEMENTIA PHARMACEUTICALS INC | Hoofd Techniek/Wetenschap/O&O | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AMARIN CORPORATION PLC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Clementia Pharmaceuticals, Inc.
 Clementia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Clementia Pharmaceuticals, Inc. provides healthcare services. It is a biopharmaceutical company, which focuses on exploiting the science of novel retinoic acid receptor gamma agonists to address bone disease and involves in development and commercialization of treatments for people living with rare diseases. Clementia Pharmaceuticals was founded by Clarissa Desjardins and Jean-Claude Tardif on November 5, 2010 and is headquartered in Montreal, Canada. | Health Technology |
